Introduction: Dyspnoe due to diafragmal paralysis can arise due to paradoxal movement and subsequent dysfunction of the lung above. Also after pneumonectomy elevation of the diaphragm can negatively influence the cardial function and provoke dyspnoe or cardiovascular dysfunction. During this presentation a new physiological explanation of the phenomenon of cardiac dysfunction due to the rise in diaphragm will be discussed. Plication of the diafragm is the treatment of choice in these patients with cardial dysfunction. Methods: Patients with an elevated diaphragm and dyspnoe or cardial dysfunction were analyzed. All patients underwent cardial and pulmonary functional tests. The paradoxal movement and influence of the diaphragm on lung and cardiac function was evaluated using dynamic MRI. In patients with cardiac dysfunction we proved this physiology with pulmonary artery pressure measurements in different positions. Correction was performed either trough a low anterior thoracotomy or thoracoscopically. Postoperative the correction of the diaphragm was confirmed with plain AP X-rays of the thorax. The effect of the operation was evaluated with new functional tests. A total of 3 patients will be discussed. Results: One patient had developed a right to left shunt through a patent Foramen Ovale as a result of direct compression of the right ventricle and atrium by the elevated liver after right pneumonectomy. We have proved in this patient that the elevated right diaphragm caused the shunting as this shunt disappeared after correction of the position of the diaphragm. Postoperative the effect on the right ventricle and the shunt was proved with a repeated 100% breathingtest. In her case however the success was not lasting and new dysfunction appeared. In two patients without a patent Foramen Ovale or other interatrial defects a shunt did not appear but dyspnoea d' effort and collapse during Valsalva manoeuvre as a result of intermittent right ventricular dysfunction were the symptoms. These patients are no longer oxygen dependent or dyspnoeic and have a greatly improved social live after operation. Discussion: The influence of a paradoxal movement of the diaphragm on lungfunction is a known phenomenon. The influence of the diaphragm on the right ventricular function has not been described earlier.
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We have proved in 3 patients that dysfunction of the right ventricle due to an elevated diaphragm can be corrected with a good functional result. In patients with dyspnoe and collapse with suspicion of right ventricular compression due to the elevated diaphragm further analysis is warranted and reefing of the diaphragm should be considered in selected cases. To evaluate the effectiveness of image-guided radiation therapy with ExacTrac X-ray system (BrainLAB) for improving setup accuracy and respiratory gating system for minimizing target volume uncertainty of body-frame based stereotactic radiosurgery (SRS) in lung tumor Methods: Fifty-two stereotactic radiation therapies with respiratory gating system in 39 patients (two targets in seven patients and three in three patients) were executed in Asan Medical Center from May 2005 to June 2006. We used respiratory gating system consisted of RPM (Varian) and 4D-CT (GE), if tumor movement was exceeding 5mm by respiration on fluoroscopy. Accurate tumor movement on reconstructed 4D-CT image determined execution of respiratory gating therapy. Respiratory gating therapy was done if tumor movement was exceeding 5mm, and non-gating therapy was done if it was below 5mm. Additional twice CT simulation was done for verifying interfractional setup variation during SRS, and ExacTrac X-ray system was used for accomplishing accurate patients' setup. We analyzed accurate movement of lung tumor by respiration as a result of 4D-CT scanning, interfractional setup verification on additional CT simulation, and usefulness of ExacTrac system for correcting daily treatment setup error. Results: Forty tumors were treated with supine position, and the other twelve were with prone position. Median tumor movement (3-dimensional) by respiration was 7.55±5.30 mm, and it was mostly affected by cranio-caudal movement (7.2±5.33 mm). Tumor movements were different by tumor location whether upper (5.38±2.85 mm) or lower (9.95±5.36 mm) lung tumor (p=0.004), but were not different by patients' breathing time. Tumor movement was exceeding 5mm in 26 (50%) tumors, and below 5mm in 26 tumors. Tumor movements on adopted respiratory gating phase were wholly below 5mm, and its median value was 3.30±1.13 mm. Interfractional setup variation between initial CT and verification CT were 1.00±1.68 mm laterally, 1.00±1.83 mm vertically, and 2.00±2.09 longitudinally, respectively. Automatic correction shifting by ExacTrac system during actual treatment were 2.18±3.45 mm laterally, 1.93±2.32 mm vertically, and 1.63±4.23 longitudinally, respectively. Manual correction shifting by physician on setup verification film after automatic correction was not exceeding 2 mm in all treatment. Conclusions: Respiratory gating system could minimize target volume uncertainty by respiration in lung tumor, and ExacTrac system could correct automatically interfractional patients' setup error. As a result, th World Conference on Lung Cancer image-guided radiation therapy could improve the treatment accuracy of high precision stereotactic radiosurgery.
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NT The prognosis of patients with NSCLC is still poor. Amongst distant metastases, also local tumour recurrence is still a problem. Because charged particles (protons and C-ions) have a better dose-distribution than the currently used photons, at least from a theoretical point of view, they should lead to superior results compared to photons. On top of the physical superiority of protons over photons, C-ions also display a biological advantage. Aim: In this review, we searched for clinical evidence that protons or C-ions would really be beneficial to patients with NSCLC.
Methods:
We performed a review based on published literature by means of a standardized query using the following electronic databases (up until January 31, 2007): CINAHL, EMBASE and MEDLINE. There was no limit applied to publication year, language or study design. Search terms (using free text words as well as MESH terms) were used alone or in combination, related to lung cancer and charged particle treatment. This included the following terms: neoplasm, cancer, carcinoma, lung cancer, proton, ion, charged particle and hadron. Results: Six fully published series (protons:3, C-ions:3), all dealing with NSCLC, mainly stage I, were identified. No phase III trials could be identified. On proton therapy, weighted means of 2-5 year local tumour control rates varied between 68% and 84%. The weighted mean for 2 year/5 year overall survival and 2 year/5 year cause specific survival were 53%/23% and 66%/46% respectively. Radiation induced pneumonitis was observed in about 10% of the patients. On C-ion therapy, the local tumour control rate was 77% and the 5 year overall survival and cause specific survival rates were 42% and 60% respectively.
Conclusion:
The results with charged particles, at least for stage I disease, seem to be better than that which is generally achieved by conventional radiotherapy. However, they seem to be similar to what may be achieved with hypofractionated "stereotactic" photon techniques, with which in several phase I/II studies, local tumour control rates of 90 % and more were reported. Due to the overwhelming theoretical data on the beneficial properties of protons and light ions, further investment in the infrastructure needed to perform large trials in patients with different lung cancer stages, is warranted. Until these results are available, for lung cancer, charged particle therapy should be considered as experimental.
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Image guided gated setup and treatment with implanted fiducials
Balter, Peter; Lindsay, Patricia; Briere, Tina; Vedam, Sastry; Komaki, Ritsuko The UT, MD Anderson Cancer Center, Houston, TX, USA Background: Radiotherapy of tumors in the lung is often limited by the relatively low dose tolerance of the lung. One method to reduce the toxicity of these treatments is to reduce the volume of lung irradiated by using image guided setup and/or gating. The current generation of medical linear accelerators have both kVp imaging and gating, allowing the implementation of image guided gated radiotherapy. Tumors, however, are often not evident on kVp projection images, but this limitation can be overcome by the use of implanted fiducials. Methods: A patient was broncoscopically implanted with 4 fiducials. All but one was lost within the first few days after implantation, and the last one remained for the entire treatment. On each day the patient was imaged using the kVp on-board imager. The imager was triggered with the same respiratory gating system used to the gate the treatment. The fiducial was used to align the patient; if a shift was made a 2nd set of kVp images was taken to validate the shift. The fiducial was aligned using both a point matching tool (ISOLOC, CIVCO, Kalona, IA) and an image overlay tool (4DTC, Varian, Palo Alto, CA). We also validated the setup by examining the projection of the fiducial on cine images acquired during the delivery of one the treatment fields.
Results:
We were able to analyze shift data from 24 of 30 treatment days. The values of the initial shifts were -1.4±1.9, 5.3±2.2 and 0.5±2.2 mm in the lateral, cranial-caudal, and AP directions, respectively. The values of the residual error after the initial shifts calculated from the 2nd set of kVp images were -0.4±1.4, -0.6±3.5 and -0.6±1.3 mm in each direction. The point matching and image overlay systems were consistent at the 1 mm level. The cine images were taken in the AP direction and data could only be extracted for the lateral and cranial-caudal directions. These results were 0.1 ± 1.1 and 1.1 ± 2.2 mm respectively. These data suggest that the uncertainty in the gating represented about 4 mm of tumor motion. Conclusion: Fiducial-based setup of lung patients using either a pointbased or image-based system is practical using existing commercially available tools. Gating, however only reduces and does not completely eliminate tumor motion. An internal margin (IM) must therefore be included in the treatment plan to account for the uncertainty in the gated motion. Purpose: Synchrony, the respiratory tracking system of the CyberKnife requires the insertion of markers in or close to the tumor. However, in this group of inoperable patients, it is associated with high risks like pneumothorax. To reduce the risks, 4 different methods of marker placement were used: 1) intravascular coil placement, 2) percutaneous intrapulmonal, 3) percutaneous extrapulmonal placement (for fixed tumors to the thorax), and 4) the bronchoscopic placement. To evaluate these techniques, we investigated the toxicity of the marker placement and the tumor response of the treatment. Until now 70 tumors are treated, but because the follow up is too short, we report the results of the first 55 patients with 60 tumors. Methods and Materials: Markers were placed in or around 60 tumors in 55 patients. Forty eight patients were treated with curative intention: 40 patients had a T1-3N0M0 lung cancer and 8 patients had 13 solitary metastases in the lung. Seven patients were treated with palliative
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